首页> 外文期刊>Pharmaceutical Biology >Dillenia species: A review of the traditional uses, active constituents and pharmacological properties from pre-clinical studies
【24h】

Dillenia species: A review of the traditional uses, active constituents and pharmacological properties from pre-clinical studies

机译:Dillenia种:从临床前研究回顾传统用途,有效成分和药理特性

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Dillenia (Dilleniaceae) is a genus of about 100 species of flowering plants in tropical and subtropical trees of Southern Asia, Australasia, and the Indian Ocean Islands. Until now, only eight Dillenia species have been reported to be used traditionally in different countries for various medical purposes. Out of eight species, D. pentagyna (Roxb), D. indica (Linn.) and D. suffruticosa (Griffith Ex. Hook. F. & Thomsom Martelli) have been reported to be used to treat cancerous growth.
机译:背景:Dillenia(Dilleniaceae)是南亚,大洋洲和印度洋群岛的热带和亚热带树木中约100种开花植物的属。到目前为止,据报道,在不同国家传统上仅将8个Dillenia物种用于各种医疗目的。在八种物种中,据报道已将D. pentagyna(Roxb),D。indica(Linn。)和D. suffruticosa(Griffith Ex。Hook。F.&Thomsom Martelli)用于治疗癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号